Abstract
Typhoid is endemic in many parts of southeast Asia. Due to the resistance of the organism to first line of antibiotics (ampicillin, chloramphenicol, cotrimoxazole) as well as to fluoroquinolones, third generation cephalosporins have been in use for the empiric treatment of typhoid for years. However an increasing incidence of Salmonella Typhi is being reported sporadically from various regions. We report a case of typhoid due to Salmonella Typhi which was non-responsive to treatment with a cephalosporin, was found to be multidrug resistant and resistant to ciprofloxacin and third generation cephalosporin as well. The patient was finally treated successfully with intravenous administration of a carbapenem.
| Original language | English (UK) |
|---|---|
| Pages (from-to) | 1035-1036 |
| Number of pages | 2 |
| Journal | Journal of the Pakistan Medical Association |
| Volume | 66 |
| Issue number | 8 |
| Publication status | Published - 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Carbapenem
- Cephalosporin
- Salmonella Typhi
- Typhoid fever
Fingerprint
Dive into the research topics of 'Extended spectrum beta lactamase producing cephalosporin resistant Salmonella Typhi, reported from Rawalpindi, Pakistan'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver